| Product NDC: | 0615-2547 |
| Proprietary Name: | Benztropine Mesylate |
| Non Proprietary Name: | Benztropine Mesylate |
| Active Ingredient(s): | .5 mg/1 & nbsp; Benztropine Mesylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0615-2547 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089058 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100228 |
| Package NDC: | 0615-2547-31 |
| Package Description: | 31 TABLET in 1 BLISTER PACK (0615-2547-31) |
| NDC Code | 0615-2547-31 |
| Proprietary Name | Benztropine Mesylate |
| Package Description | 31 TABLET in 1 BLISTER PACK (0615-2547-31) |
| Product NDC | 0615-2547 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benztropine Mesylate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100228 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | BENZTROPINE MESYLATE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |